Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists

J Gynecol Oncol. 2020 Jul;31(4):e68. doi: 10.3802/jgo.2020.31.e68. Epub 2020 May 27.


The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.

Keywords: COVID-19; Gynecological Malignancies; Management; Pandemic; Recommendations.

Publication types

  • Review

MeSH terms

  • Betacoronavirus*
  • Coronavirus Infections / epidemiology*
  • Disease Outbreaks / statistics & numerical data
  • Female
  • Genital Neoplasms, Female / epidemiology*
  • Guidelines as Topic
  • Gynecology / standards
  • Health Planning Guidelines
  • Humans
  • Oncologists / standards
  • Pandemics
  • Pneumonia, Viral / epidemiology*

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2